Skip to main content
Erschienen in: International Journal of Legal Medicine 4/2017

24.02.2017 | Original Article

Detection and quantification of 12 anabolic steroids and analogs in human whole blood and 20 in hair using LC-HRMS/MS: application to real cases

verfasst von: Nicolas Fabresse, Stanislas Grassin-Delyle, Isabelle Etting, Jean-Claude Alvarez

Erschienen in: International Journal of Legal Medicine | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

We developed and validated a method to detect and quantify 12 anabolic steroids in blood (androstenedione, dihydrotestosterone, boldenone, epitestosterone, mesterolone, methandienone, nandrolone, stanozolol, norandrostenedione, tamoxifene, testosterone, trenbolone) and eight more in hair samples (nandrolone phenylpropionate, nandrolone decanoate, testosterone propionate, testosterone benzoate, testosterone cypionate, testosterone decanoate, testosterone phenylpropionate, testosterone undecanoate) using liquid chromatography coupled to high-resolution mass spectrometry. This method used a benchtop Orbitrap mass spectrometer operating with an APCI probe under positive ionization mode. Analysis was realized in full scan experiment with a nominal resolving power of 140,000. After addition of the internal standard (testosterone-D3) and incubation in phosphate buffer pH = 5 for hair, 200 μL of blood and 30 mg of hair samples were extracted with heptane. LOQ and LOD were determined at 5 and 1 ng mL−1 in whole blood and 10 to 100 pg mg−1 and 2 to 20 pg mg−1 in hair according to the compounds, respectively. The method was linear in the 5–1000 ng mL−1 range in whole blood and between 10 or 100 pg mg−1 and 1000 pg mg−1 in hair with correlation coefficients >0.99, and intra- and inter-day accuracy and precision were <14.8% for all compounds except for some esters in hairs (<19.9%) probably due to an important matrix effect for these compounds. This sensitive and specific method to detect anabolic steroids has been successfully applied to two real cases, for which various anabolic steroids in whole blood, urine, and hair were identified and quantified.
Literatur
1.
Zurück zum Zitat K David, E Dingemanse, J Freud, E Laquer (1935) Uber Krystallinisches mannliches Hormon Hoden (Testosteron), wirksamer als aus Harn oder aus Cholesterin Bereitetes Androsteron. Zeit Physiol Chem 281–282 K David, E Dingemanse, J Freud, E Laquer (1935) Uber Krystallinisches mannliches Hormon Hoden (Testosteron), wirksamer als aus Harn oder aus Cholesterin Bereitetes Androsteron. Zeit Physiol Chem 281–282
2.
Zurück zum Zitat World Anti-Doping Agency (WADA) (2014) 2014 Anti-Doping Testing Figures Report World Anti-Doping Agency (WADA) (2014) 2014 Anti-Doping Testing Figures Report
3.
Zurück zum Zitat Yesalis CE, Barsukiewicz CK, Kopstein AN, Bahrke MS (1997) Trends in anabolic-androgenic steroid use among adolescents. Arch Pediatr Adolesc Med 151:1197–1206CrossRefPubMed Yesalis CE, Barsukiewicz CK, Kopstein AN, Bahrke MS (1997) Trends in anabolic-androgenic steroid use among adolescents. Arch Pediatr Adolesc Med 151:1197–1206CrossRefPubMed
4.
Zurück zum Zitat Buckley WE, Yesalis CE, Friedl KE et al (1988) Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 260:3441–3445CrossRefPubMed Buckley WE, Yesalis CE, Friedl KE et al (1988) Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 260:3441–3445CrossRefPubMed
5.
Zurück zum Zitat Yesalis CE, Anderson WA, Buckley WE, Wright JE (1990) Incidence of the nonmedical use of anabolic-androgenic steroids. NIDA Res Monogr 102:97–112PubMed Yesalis CE, Anderson WA, Buckley WE, Wright JE (1990) Incidence of the nonmedical use of anabolic-androgenic steroids. NIDA Res Monogr 102:97–112PubMed
6.
Zurück zum Zitat Rachoń D, Pokrywka L, Suchecka-Rachoń K (2006) Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland. Soz- Präventivmedizin 51:392–398CrossRef Rachoń D, Pokrywka L, Suchecka-Rachoń K (2006) Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland. Soz- Präventivmedizin 51:392–398CrossRef
7.
Zurück zum Zitat Hakansson A, Mickelsson K, Wallin C, Berglund M (2012) Anabolic androgenic steroids in the general population: user characteristics and associations with substance use. Eur Addict Res 18:83–90. doi:10.1159/000333037 CrossRefPubMed Hakansson A, Mickelsson K, Wallin C, Berglund M (2012) Anabolic androgenic steroids in the general population: user characteristics and associations with substance use. Eur Addict Res 18:83–90. doi:10.​1159/​000333037 CrossRefPubMed
8.
Zurück zum Zitat Hullstein IR, Malerod-Fjeld H, Dehnes Y, Hemmersbach P (2015) Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples. Drug Test Anal 7:1025–1029. doi:10.1002/dta.1900 CrossRefPubMed Hullstein IR, Malerod-Fjeld H, Dehnes Y, Hemmersbach P (2015) Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples. Drug Test Anal 7:1025–1029. doi:10.​1002/​dta.​1900 CrossRefPubMed
11.
Zurück zum Zitat Pagonis TA, Angelopoulos NV, Koukoulis GN, Hadjichristodoulou CS (2006) Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse. Eur Psychiatry J Assoc Eur Psychiatr 21:551–562. doi:10.1016/j.eurpsy.2005.09.001 CrossRef Pagonis TA, Angelopoulos NV, Koukoulis GN, Hadjichristodoulou CS (2006) Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse. Eur Psychiatry J Assoc Eur Psychiatr 21:551–562. doi:10.​1016/​j.​eurpsy.​2005.​09.​001 CrossRef
14.
15.
Zurück zum Zitat Hourigan LA, Rainbird AJ, Dooris M (1998) Intracoronary stenting for acute myocardial infarction (AMI) in a 24-year-old man using anabolic androgenic steroids. Aust NZ J Med 28:838–839CrossRef Hourigan LA, Rainbird AJ, Dooris M (1998) Intracoronary stenting for acute myocardial infarction (AMI) in a 24-year-old man using anabolic androgenic steroids. Aust NZ J Med 28:838–839CrossRef
16.
Zurück zum Zitat De La Torre R, De La Torre X, Segura J et al (1998) Recent advances in doping analysis. Sport Buch Strauβ Köln:223–236 De La Torre R, De La Torre X, Segura J et al (1998) Recent advances in doping analysis. Sport Buch Strauβ Köln:223–236
17.
Zurück zum Zitat Shackleton CH, Chuang H, Kim J et al (1997) Electrospray mass spectrometry of testosterone esters: potential for use in doping control. Steroids 62:523–529CrossRefPubMed Shackleton CH, Chuang H, Kim J et al (1997) Electrospray mass spectrometry of testosterone esters: potential for use in doping control. Steroids 62:523–529CrossRefPubMed
18.
Zurück zum Zitat Rogozkin VA, Morozov VI, Tchaikovsky VS (1979) Rapid radioimmunoassay for anabolic steroids in urine. Schweiz Z Für Sportmed 27:169–173 Rogozkin VA, Morozov VI, Tchaikovsky VS (1979) Rapid radioimmunoassay for anabolic steroids in urine. Schweiz Z Für Sportmed 27:169–173
19.
21.
Zurück zum Zitat Kintz P, Cirimele V, Jeanneau T, Ludes B (1999) Identification of testosterone and testosterone esters in human hair. J Anal Toxicol 23:352–356CrossRefPubMed Kintz P, Cirimele V, Jeanneau T, Ludes B (1999) Identification of testosterone and testosterone esters in human hair. J Anal Toxicol 23:352–356CrossRefPubMed
25.
Zurück zum Zitat Dumestre-Toulet V, Cirimele V, Ludes B et al (2002) Hair analysis of seven bodybuilders for anabolic steroids, ephedrine, and clenbuterol. J Forensic Sci 47:211–214CrossRefPubMed Dumestre-Toulet V, Cirimele V, Ludes B et al (2002) Hair analysis of seven bodybuilders for anabolic steroids, ephedrine, and clenbuterol. J Forensic Sci 47:211–214CrossRefPubMed
27.
Zurück zum Zitat Kintz P, Cirimele V, Sachs H et al (1999) Testing for anabolic steroids in hair from two bodybuilders. Forensic Sci Int 101:209–216CrossRefPubMed Kintz P, Cirimele V, Sachs H et al (1999) Testing for anabolic steroids in hair from two bodybuilders. Forensic Sci Int 101:209–216CrossRefPubMed
28.
Zurück zum Zitat Gaillard Y, Vayssette F, Pépin G (2000) Compared interest between hair analysis and urinalysis in doping controls: results for amphetamines, corticosteroids and anabolic steroids in racing cyclists. Forensic Sci Int 107:361–379. doi:10.1016/S0379-0738(99)00179-6 CrossRefPubMed Gaillard Y, Vayssette F, Pépin G (2000) Compared interest between hair analysis and urinalysis in doping controls: results for amphetamines, corticosteroids and anabolic steroids in racing cyclists. Forensic Sci Int 107:361–379. doi:10.​1016/​S0379-0738(99)00179-6 CrossRefPubMed
30.
Zurück zum Zitat Baba S, Fujioka M, Shinohara Y, Furuta T (1985) Determination of testosterone propionate in human plasma by gas chromatography-mass spectrometry. J Chromatogr 337:205–212CrossRefPubMed Baba S, Fujioka M, Shinohara Y, Furuta T (1985) Determination of testosterone propionate in human plasma by gas chromatography-mass spectrometry. J Chromatogr 337:205–212CrossRefPubMed
31.
Zurück zum Zitat Fung EN, Xia Y, Aubry A-F et al (2011) Full-scan high resolution accurate mass spectrometry (HRMS) in regulated bioanalysis: LC-HRMS for the quantitation of prednisone and prednisolone in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 879:2919–2927. doi:10.1016/j.jchromb.2011.08.025 CrossRefPubMed Fung EN, Xia Y, Aubry A-F et al (2011) Full-scan high resolution accurate mass spectrometry (HRMS) in regulated bioanalysis: LC-HRMS for the quantitation of prednisone and prednisolone in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 879:2919–2927. doi:10.​1016/​j.​jchromb.​2011.​08.​025 CrossRefPubMed
32.
Zurück zum Zitat Georgakopoulos CG, Vonaparti A, Stamou M et al (2007) Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids. Rapid Commun Mass Spectrom RCM 21:2439–2446. doi:10.1002/rcm.3103 CrossRefPubMed Georgakopoulos CG, Vonaparti A, Stamou M et al (2007) Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids. Rapid Commun Mass Spectrom RCM 21:2439–2446. doi:10.​1002/​rcm.​3103 CrossRefPubMed
33.
Zurück zum Zitat Touber ME, van Engelen MC, Georgakopoulus C et al (2007) Multi-detection of corticosteroids in sports doping and veterinary control using high-resolution liquid chromatography/time-of-flight mass spectrometry. Anal Chim Acta 586:137–146. doi:10.1016/j.aca.2006.09.058 CrossRefPubMed Touber ME, van Engelen MC, Georgakopoulus C et al (2007) Multi-detection of corticosteroids in sports doping and veterinary control using high-resolution liquid chromatography/time-of-flight mass spectrometry. Anal Chim Acta 586:137–146. doi:10.​1016/​j.​aca.​2006.​09.​058 CrossRefPubMed
34.
Zurück zum Zitat Kolmonen M, Leinonen A, Kuuranne T et al (2009) Generic sample preparation and dual polarity liquid chromatography-time-of-flight mass spectrometry for high-throughput screening in doping analysis. Drug Test Anal 1:250–266. doi:10.1002/dta.50 CrossRefPubMed Kolmonen M, Leinonen A, Kuuranne T et al (2009) Generic sample preparation and dual polarity liquid chromatography-time-of-flight mass spectrometry for high-throughput screening in doping analysis. Drug Test Anal 1:250–266. doi:10.​1002/​dta.​50 CrossRefPubMed
35.
Zurück zum Zitat Girón AJ, Deventer K, Roels K, Van Eenoo P (2012) Development and validation of an open screening method for diuretics, stimulants and selected compounds in human urine by UHPLC-HRMS for doping control. Anal Chim Acta 721:137–146. doi:10.1016/j.aca.2012.02.002 CrossRefPubMed Girón AJ, Deventer K, Roels K, Van Eenoo P (2012) Development and validation of an open screening method for diuretics, stimulants and selected compounds in human urine by UHPLC-HRMS for doping control. Anal Chim Acta 721:137–146. doi:10.​1016/​j.​aca.​2012.​02.​002 CrossRefPubMed
37.
Zurück zum Zitat Gray BP, Viljanto M, Bright J et al (2013) Investigations into the feasibility of routine ultra high performance liquid chromatography-tandem mass spectrometry analysis of equine hair samples for detecting the misuse of anabolic steroids, anabolic steroid esters and related compounds. Anal Chim Acta 787:163–172. doi:10.1016/j.aca.2013.05.058 CrossRefPubMed Gray BP, Viljanto M, Bright J et al (2013) Investigations into the feasibility of routine ultra high performance liquid chromatography-tandem mass spectrometry analysis of equine hair samples for detecting the misuse of anabolic steroids, anabolic steroid esters and related compounds. Anal Chim Acta 787:163–172. doi:10.​1016/​j.​aca.​2013.​05.​058 CrossRefPubMed
38.
Zurück zum Zitat van der Heeft E, Bolck YJC, Beumer B et al (2009) Full-scan accurate mass selectivity of ultra-performance liquid chromatography combined with time-of-flight and orbitrap mass spectrometry in hormone and veterinary drug residue analysis. J Am Soc Mass Spectrom 20:451–463. doi:10.1016/j.jasms.2008.11.002 CrossRefPubMed van der Heeft E, Bolck YJC, Beumer B et al (2009) Full-scan accurate mass selectivity of ultra-performance liquid chromatography combined with time-of-flight and orbitrap mass spectrometry in hormone and veterinary drug residue analysis. J Am Soc Mass Spectrom 20:451–463. doi:10.​1016/​j.​jasms.​2008.​11.​002 CrossRefPubMed
39.
Zurück zum Zitat Thieme D, Grosse J, Sachs H, Mueller RK (2000) Analytical strategy for detecting doping agents in hair. Forensic Sci Int 107:335–345CrossRefPubMed Thieme D, Grosse J, Sachs H, Mueller RK (2000) Analytical strategy for detecting doping agents in hair. Forensic Sci Int 107:335–345CrossRefPubMed
40.
Zurück zum Zitat Kintz P, Cirimele V, Dumestre-Toulet V, Ludes B (2001) Doping control for nandrolone using hair analysis. J Pharm Biomed Anal 24:1125–1130CrossRefPubMed Kintz P, Cirimele V, Dumestre-Toulet V, Ludes B (2001) Doping control for nandrolone using hair analysis. J Pharm Biomed Anal 24:1125–1130CrossRefPubMed
41.
Zurück zum Zitat Pozo OJ, Deventer K, Van Eenoo P et al (2009) Quantification of testosterone undecanoate in human hair by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr BMC 23:873–880. doi:10.1002/bmc.1199 CrossRefPubMed Pozo OJ, Deventer K, Van Eenoo P et al (2009) Quantification of testosterone undecanoate in human hair by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr BMC 23:873–880. doi:10.​1002/​bmc.​1199 CrossRefPubMed
42.
44.
Zurück zum Zitat Wheeler MJ, Zhong YB, Kicman AT, Coutts SB (1998) The measurement of testosterone in hair. J Endocrinol 159:R5–R8CrossRefPubMed Wheeler MJ, Zhong YB, Kicman AT, Coutts SB (1998) The measurement of testosterone in hair. J Endocrinol 159:R5–R8CrossRefPubMed
45.
Zurück zum Zitat Mewis C, Spyridopoulos I, Kühlkamp V, Seipel L (1996) Manifestation of severe coronary heart disease after anabolic drug abuse. Clin Cardiol 19:153–155CrossRefPubMed Mewis C, Spyridopoulos I, Kühlkamp V, Seipel L (1996) Manifestation of severe coronary heart disease after anabolic drug abuse. Clin Cardiol 19:153–155CrossRefPubMed
47.
Zurück zum Zitat Dehennin L, Ferry M, Lafarge P et al (1998) Oral administration of dehydroepiandrosterone to healthy men: alteration of the urinary androgen profile and consequences for the detection of abuse in sport by gas chromatography-mass spectrometry. Steroids 63:80–87. doi:10.1016/S0039-128X(97)00138-4 CrossRefPubMed Dehennin L, Ferry M, Lafarge P et al (1998) Oral administration of dehydroepiandrosterone to healthy men: alteration of the urinary androgen profile and consequences for the detection of abuse in sport by gas chromatography-mass spectrometry. Steroids 63:80–87. doi:10.​1016/​S0039-128X(97)00138-4 CrossRefPubMed
48.
Zurück zum Zitat Bosy TZ, Moore KA, Poklis A (1998) The effect of oral dehydroepiandrosterone (DHEA) on the urine testosterone/epitestosterone (T/E) ratio in human male volunteers. J Anal Toxicol 22:455–459CrossRefPubMed Bosy TZ, Moore KA, Poklis A (1998) The effect of oral dehydroepiandrosterone (DHEA) on the urine testosterone/epitestosterone (T/E) ratio in human male volunteers. J Anal Toxicol 22:455–459CrossRefPubMed
49.
Zurück zum Zitat Bowers LD (1999) Oral dehydroepiandrosterone supplementation can increase the testosterone/epitestosterone ratio. Clin Chem 45:295–297PubMed Bowers LD (1999) Oral dehydroepiandrosterone supplementation can increase the testosterone/epitestosterone ratio. Clin Chem 45:295–297PubMed
50.
Zurück zum Zitat Kintz P, Cirimele V, Deveaux M, Ludes B (2000) Dehydroepiandrosterone (DHEA) and testosterone concentrations in human hair after chronic DHEA supplementation. Clin Chem 46:414–415PubMed Kintz P, Cirimele V, Deveaux M, Ludes B (2000) Dehydroepiandrosterone (DHEA) and testosterone concentrations in human hair after chronic DHEA supplementation. Clin Chem 46:414–415PubMed
Metadaten
Titel
Detection and quantification of 12 anabolic steroids and analogs in human whole blood and 20 in hair using LC-HRMS/MS: application to real cases
verfasst von
Nicolas Fabresse
Stanislas Grassin-Delyle
Isabelle Etting
Jean-Claude Alvarez
Publikationsdatum
24.02.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Legal Medicine / Ausgabe 4/2017
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-017-1552-3

Weitere Artikel der Ausgabe 4/2017

International Journal of Legal Medicine 4/2017 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …